Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: The therapeutic efficacy of intensive medical therapy in ameliorating high-density lipoprotein dysfunction in subjects with type two diabetes

Lipids in Health and Disease201615:191

https://doi.org/10.1186/s12944-016-0362-9

  • Published:

The original article was published in Lipids in Health and Disease 2016 15:141

Erratum

After publication of the original article [1], it came to the authors’ attention that a source of funding was not disclosed in the Declarations section of the paper. The study was in part supported by the American Diabetes Association (1-15-IN-31). The Funding section of the original article should have acknowledged this grant.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Departemnt of Endocrinology and Metabolism, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
(2)
Department of Core Facilities, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
(3)
Department of Quantitative Health Sciences, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
(4)
Department of Hepatology, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
(5)
Present address: Department of Pharmaceutical Sciences, Northeast Ohio Medical University, 4209 St. R. 44, PO Box 95, Rootstown, OH 44272, USA

Reference

  1. Kashyap S, Kheniser K, Li L, Bena J, Kasumov T. The therapeutic efficacy of intensive medical therapy in ameliorating high-density lipoprotein dysfunction in subjects with type two diabetes. Lipids Health Dis. 2016;15:141. doi:10.1186/s12944-016-0314-4.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

Advertisement